how often should glp 1 be taken Patients who stop GLP-1 drugs restart or try alternatives GLP-1 Medication Schedule: Dosing Frequency

In a Phase II trial, retatrutide demonstrated a mean weight reduction of over 17.5% in adults without diabetes but with obesity or pre-obesity, marking a significant advancement in weight management therapies

In addition, SGLT-2 inhibitors have shown benefit in patients with both HFrEF and HFpEF independently of diabetes status, which opens exciting possibilities for the use of these therapies in patients at risk for or with established CV or kidney disease without T2D

Okay, lets be honest about it This is about PBMs wanting to steer patients to their pharmacy for one reason, and one reason only, economics

View our full shipping policy